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Introduction
Enteral supplementation of probiotics has been demon-
strated to reduce the risk of severe necrotizing enteroco-
litis (NEC) and all-cause mortality in preterm infants.
Objectives
This retrospective analysis aimed to assess the frequency of
NEC and sepsis in preterm infants with birth weights less
than 1,500 grams (VLBW infants), before and after the
implementation of prophylactic enteral administration of
probiotics in German neonatal intensive care units (NICUs).
Methods
This multicenter study is based on NEO-KISS, the German
surveillance system for nosocomial infections in VLBW
infants. All NICUs that implemented prophylactic enteral
administration of probiotics with ≥ 2 strains for VLBW
infants were included in the analysis. Data of VLBW infants
that were admitted between 36 months before and 36
months after the implementation of probiotics were ana-
lyzed. Study period was 2004 – 2014. Interrupted time ser-
ies analyses were applied to evaluate longitudinal effects of
the exposition (probiotics) on the frequency of i) NEC, ii)
sepsis and iii) all-cause mortality. Risk factor analyses
included Cox proportional hazard regression estimating
hazard ratios (HR) with 95 % confidence intervals (95 % CI).
Results
The data of 10,890 VLBW infants - including 4,683 infants
with a birth weight below 1,000 grams (ELBW infants) -
from 44 neonatal departments were included in this study.
Incidences of NEC and sepsis were 2.5 % (n = 274) and
15.0 % (n = 1631) in VLBW infants; 4.6 % (n = 215) and
24.2 % (n = 1133) in ELBW infants. The use of probiotics
significantly reduced the risk of NEC (HR = 0.48; 95% CI =
0.39 – 0.62), all-cause mortality (HR = 0.60, 95 % CI = 0.44
– 0.83) and sepsis (HR = 0.89, 95 % CI = 0.81 – 0.98). The
subgroup analysis in the ELBW infants cohort showed an
even more pronounced positive effect of probiotics on NEC
(HR = 0.48, 95 % CI = 0.36 – 0.64), all-cause mortality (HR
= 0.59, 95 % CI = 0.41 – 0.84) and even sepsis (HR = 0.83,
95 % CI = 0.71 – 0.94).
Conclusion
This large multicenter study provides evidence that pro-
phylactic enteral probiotics administration significantly
reduces complications of premature birth. Routine probio-
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